These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10218852)

  • 1. Three AML patients with existing or pre-existing intracerebral granulocytic sarcomas who were successfully treated with allogeneic bone marrow transplantations.
    Takada S; Ito K; Sakura T; Hatsumi N; Sato M; Saito T; Shiozaki H; Matsushima T; Miyawaki S
    Bone Marrow Transplant; 1999 Apr; 23(7):731-4. PubMed ID: 10218852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
    Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
    Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation.
    Koc Y; Miller KB; Schenkein DP; Daoust P; Sprague K; Berkman E
    Cancer; 1999 Feb; 85(3):608-15. PubMed ID: 10091734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmyeloablative allogeneic bone marrow transplantation for orbital granulocytic sarcoma associated with t(8;21)(q22;q22) in acute myeloid leukemia.
    Hung GY; Chiou TJ; Hsieh YL; Chen PM; Hwang B
    Bone Marrow Transplant; 2002 Jan; 29(1):67-70. PubMed ID: 11840147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term leukemia-free survival after allogeneic marrow transplantation in patients with acute myelogenous leukemia.
    Greinix HT; Keil F; Brugger SA; Reiter E; Linkesch W; Lechner K; Schneider B; Dieckmann KU; Fischer G; Schwarzinger I; Haas O; Hinterberger W; Mannhalter C; Geissler K; Hocker P; Jager U; Kalhs P
    Ann Hematol; 1996 Feb; 72(2):53-9. PubMed ID: 8597607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent isolated extramedullary relapses as granulocytic sarcomas following allogeneic bone marrow transplantation for acute myeloid leukemia.
    Au WY; Chan AC; Lie AK; Chen FE; Liang R; Kwong YL
    Bone Marrow Transplant; 1998 Jan; 21(2):205-8. PubMed ID: 9489639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation for children with acute myelogenous leukaemia in the first complete remission.
    Matsuyama T; Horibe K; Kato K; Kojima SS
    Eur J Cancer; 2000 Feb; 36(3):368-75. PubMed ID: 10708939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia.
    Clift RA; Buckner CD; Appelbaum FR; Schoch G; Petersen FB; Bensinger WI; Sanders J; Sullivan KM; Storb R; Singer J
    J Clin Oncol; 1992 Nov; 10(11):1723-9. PubMed ID: 1403055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic bone marrow transplantation remains an efficient consolidation for adults with acute myeloid leukemia even when performed very soon after diagnosis (< 100 days). The SFGM (Société Française de Greffe de Moelle.
    Jourdan E; Maraninchi D; Reiffers J; Archimbaud E; Michallet M; Harousseau JL; Ifrah N; Rio B; Guyotat D; Guilhot F
    Leukemia; 1995 Jun; 9(6):1068-71. PubMed ID: 7596171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypocellular acute myeloid leukemia treated with bone marrow transplantation.
    Keino D; Kondoh K; Ohyama R; Morimoto M; Mori T; Ito M; Kinoshita A
    Pediatr Int; 2017 Apr; 59(4):490-493. PubMed ID: 28401745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
    J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia. Société Française de Greffe de Moelle (SFGM).
    Jourdan E; Maraninchi D; Reiffers J; Gluckman E; Rio B; Jouet JP; Michallet M; Molina L; Archimbaud E; Harousseau JL; Ifrah N; Attal M; Guilhot F; Kuentz M; Guyotat D; Pico JL; Dauriac C; Legros M; Dreyfus F; Bordigoni P; Leblond V; Gratecos N; Varet B; Auzanneau C; Blaise D
    Bone Marrow Transplant; 1997 May; 19(9):875-81. PubMed ID: 9156260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation.
    Bacigalupo A; Vitale V; Corvò R; Barra S; Lamparelli T; Gualandi F; Mordini N; Berisso G; Bregante S; Raiola AM; Van Lint MT; Frassoni F
    Br J Haematol; 2000 Jan; 108(1):99-104. PubMed ID: 10651732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous or allogeneic bone marrow transplantation for acute myeloblastic leukemia in second complete remission. Importance of duration of first complete remission in final outcome.
    Tomás F; Gómez-García de Soria V; López-Lorenzo JL; Arranz R; Figuera A; Cámara R; Alegre A; Fernández-Rañada JM
    Bone Marrow Transplant; 1996 Jun; 17(6):979-84. PubMed ID: 8807103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
    Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Cytoreduction with CAG (cytarabine, Aclarubicin and G-CSF) Therapy in Refractory Acute Myelogenous Leukemia before Allogeneic Stem Cell Transplantation.
    Murayama T; Imoto S; Gomyo H; Mizuno I; Kajimoto K; Sugimoto T; Tobinai K; Koizumi T
    Hematology; 2001; 6(6):381-5. PubMed ID: 27405694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. Catalan Group for Bone Marrow Transplantation.
    Sierra J; Brunet S; Grañena A; Olivé T; Bueno J; Ribera JM; Petit J; Besses C; Llorente A; Guardia R; Macía J; Rovira M; Badell I; Vela E; Díaz de Heredia C; Vivancos P; Carreras E; Feliu E; Montserrat E; Julía A; Cubells J; Rozman C; Domingo A; Ortega JJ
    J Clin Oncol; 1996 Apr; 14(4):1353-63. PubMed ID: 8648394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early occurrence of an adenocarcinoma after allogeneic bone marrow transplantation in a patient with AML.
    Germing U; Kobbe G; Sohngen D; Motherby H; Braunstein S; Heyll A; Aul C
    Oncol Rep; 1999; 6(4):855-7. PubMed ID: 10373670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.